Clinical Trials
12 trialsNCT06305962 2026-02-19
177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors
Radiopharm Theranostics, Ltd
Phase EARLY_PHASE1 Recruiting
NCT07316361 2026-01-07
GYNORYLAQâ„¢
Biogenea Pharmaceuticals Ltd.
Phase EARLY_PHASE1 Enrolling by invitation
NCT04630353 2025-09-12
A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer
Hookipa Biotech GmbH
Phase EARLY_PHASE1 Terminated
NCT03514121 2024-11-22
FPA150-001
Five Prime Therapeutics, Inc.
Phase EARLY_PHASE1 Terminated
NCT06284226 2024-04-16
CCT-ANK-11
Beijing Kejing Biotechnology Co., Ltd.
Phase EARLY_PHASE1 Withdrawn
NCT05465590 2023-12-21
A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Cancer
Mainline Biosciences, Inc.
Phase EARLY_PHASE1 Withdrawn
NCT05886075 2023-06-02
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Unknown
NCT05812677 2023-04-14
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Unknown
NCT05801783 2023-04-06
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Unknown
NCT04674488 2020-12-19
TILs for Treatment of Metastatic or Recurrent Cervical Cancer
Shanghai OriginCell Therapeutics Co., Ltd.
Phase EARLY_PHASE1 Unknown
NCT04503980 2020-08-07
αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors
Shanghai Cell Therapy Group Co.,Ltd
Phase EARLY_PHASE1 Unknown
NCT03692637 2019-01-31
Study of Anti-Mesothelin Car NK Cells in Epithelial Ovarian Cancer
Allife Medical Science and Technology Co., Ltd.
Phase EARLY_PHASE1 Unknown